Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
4.110
+0.190 (4.85%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Decoy Therapeutics Market Cap
Decoy Therapeutics has a market cap or net worth of $2.19 million as of August 3, 2026. Its market cap has increased by 31.30% in one year.
Market Cap
2.19M
Enterprise Value
-5.63M
1-Year Change
31.30%
Ranking
Category
Stock Price
$4.11
ChartMarket Cap Chart
Since July 22, 2019, Decoy Therapeutics's market cap has decreased from $44.18M to $2.19M, a decrease of -95.05%. That is a compound annual growth rate of -34.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.19M | -47.21% |
| Dec 31, 2025 | 4.14M | 56.21% |
| Dec 31, 2024 | 2.65M | 3.58% |
| Dec 29, 2023 | 2.56M | -26.55% |
| Dec 30, 2022 | 3.49M | -84.43% |
| Dec 31, 2021 | 22.39M | 3.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clearmind Medicine | 2.51M |
| Creative Medical Technology Holdings | 2.45M |
| GRI Bio | 2.44M |
| Propanc Biopharma | 2.30M |
| Oragenics | 2.26M |
| Azitra | 2.15M |
| Moleculin Biotech | 2.13M |
| Virax Biolabs Group | 2.09M |